Lectin compositions and uses thereof
US6110891A · kind A · utility
37Cited by
3References
75Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 1998 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Aug 28, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods for: the control of mucosal cell proliferation; the reduction and/or treatment of damage caused by a cell-damaging agent; and for the reduction and/or treatment of a metabolic disorder. The methods comprise administering to an individual in need of control or reduction and/or treatment on effective amount of a lectin. The invention takes advantageous of the protective and repair capabilities of lectins. It is particularly useful in the prevention and treatment of animals undergoing radiotherapy and/or chemotherapy for cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.